BISPECIFIC TARGETING OF CHI3L1 AND PD-1/PD-L1 AXIS AS A NOVEL THERAPEUTIC STRATEGY FOR IDIOPATHIC PULMONARY FIBROSIS
$318,628FY2022Defense Health AgencyDOD
Brown University, Providence RI
Investigators
View source on USAspending →BISPECIFIC TARGETING OF CHI3L1 AND PD-1/PD-L1 AXIS AS A NOVEL THERAPEUTIC STRATEGY FOR IDIOPATHIC PULMONARY FIBROSIS · GrantIndex